Liver disease is also highly impacted by CHIP, with VAF ≥ 10% doubling the risk of chronic liver disease (CLD), nonalcoholic hepatic steatosis, and cirrhosis in CHIP carriers. The gene discussed is STUB1; the disease is congenital secretory chloride diarrhea 1.